118 related articles for article (PubMed ID: 32424860)
1. The inhibitory effects of shikonin and β,β-dimethylacrylshikonin on tramadol metabolism in vitro and in vivo.
Jin M; Shi D; Jin H; Zhou Z; Wang C
J Pharm Pharmacol; 2020 Sep; 72(9):1232-1238. PubMed ID: 32424860
[TBL] [Abstract][Full Text] [Related]
2. Metabolic interactions of magnolol with cytochrome P450 enzymes: uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C.
Kim SB; Kang HE; Cho HJ; Kim YS; Chung SJ; Yoon IS; Kim DD
Drug Dev Ind Pharm; 2016; 42(2):263-9. PubMed ID: 26133083
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of herb-drug interaction of ambrisentan with shikonin based on UPLC-MS/MS.
Lan T; Fang P; Ye X; Lan X; Xu RA
Pharm Biol; 2021 Dec; 59(1):1133-1138. PubMed ID: 34410882
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive properties of shikonin: in vitro and in vivo studies.
Gupta B; Chakraborty S; Saha S; Chandel SG; Baranwal AK; Banerjee M; Chatterjee M; Chaudhury A
Can J Physiol Pharmacol; 2016 Jul; 94(7):788-96. PubMed ID: 27223482
[TBL] [Abstract][Full Text] [Related]
5. The effect of shikonin on the metabolism of lapatinib in vitro, and in vivo.
Hu Y; Xie S; Xia H; Chen J; Yang Y; Zhan R
Toxicol Appl Pharmacol; 2024 Jan; 482():116797. PubMed ID: 38160892
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay.
Tang S; Chen A; Zhou X; Zeng L; Liu M; Wang X
Toxicol Lett; 2017 Nov; 281():74-83. PubMed ID: 28941798
[TBL] [Abstract][Full Text] [Related]
7. [Stereoselectivity in O-demethylation of trans tramadol in rat liver microsomes in vitro].
Wang N; Liu HC; Liu CS; Hou YN
Yao Xue Xue Bao; 2002 Mar; 37(3):169-74. PubMed ID: 12579754
[TBL] [Abstract][Full Text] [Related]
8. Stereoselectivity in trans-tramadol metabolism and trans-O-demethyltramadol formation in rat liver microsomes.
Liu HC; Wang N; Yu Y; Hou YN
Acta Pharmacol Sin; 2003 Jan; 24(1):85-90. PubMed ID: 12511234
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of β,β-dimethylacrylshikonin on hepatocellular carcinoma in vitro and in vivo.
Wu YY; Wan LH; Zheng XW; Shao ZJ; Chen J; Chen XJ; Liu LT; Kuang WJ; Tan XS; Zhou LM
Phytother Res; 2012 May; 26(5):764-71. PubMed ID: 22109831
[TBL] [Abstract][Full Text] [Related]
10. Effects of drug-drug interactions and CYP3A4 variants on alectinib metabolism.
Liu YN; Chen J; Wang J; Li Q; Hu GX; Cai JP; Lin G; Xu RA
Arch Toxicol; 2023 Aug; 97(8):2133-2142. PubMed ID: 37209178
[TBL] [Abstract][Full Text] [Related]
11. [Gender-related differences in metabolism of the enantiomers of trans tramadol and trans O-demethyltramadol in rat liver microsomes].
Jin SM; Liu HC
Yao Xue Xue Bao; 2004 Aug; 39(8):581-5. PubMed ID: 15563056
[TBL] [Abstract][Full Text] [Related]
12. Effects of dacomitinib on the pharmacokinetics of poziotinib
Ji W; Shen J; Wang B; Chen F; Meng D; Wang S; Dai D; Zhou Y; Wang C; Zhou Q
Pharm Biol; 2021 Dec; 59(1):457-464. PubMed ID: 33899675
[TBL] [Abstract][Full Text] [Related]
13. Physiology-based IVIVE predictions of tramadol from in vitro metabolism data.
T'jollyn H; Snoeys J; Colin P; Van Bocxlaer J; Annaert P; Cuyckens F; Vermeulen A; Van Peer A; Allegaert K; Mannens G; Boussery K
Pharm Res; 2015 Jan; 32(1):260-74. PubMed ID: 25048637
[TBL] [Abstract][Full Text] [Related]
14. Strategies for Determining Correct Cytochrome P450 Contributions in Hepatic Clearance Predictions: In Vitro-In Vivo Extrapolation as Modelling Approach and Tramadol as Proof-of Concept Compound.
T'jollyn H; Snoeys J; Van Bocxlaer J; De Bock L; Annaert P; Van Peer A; Allegaert K; Mannens G; Vermeulen A; Boussery K
Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):537-543. PubMed ID: 27317395
[TBL] [Abstract][Full Text] [Related]
15. In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates.
Zhao K; Ding M; Cao H; Cao ZX
J Pharm Pharmacol; 2012 Oct; 64(10):1445-51. PubMed ID: 22943175
[TBL] [Abstract][Full Text] [Related]
16. Impairment of vascular function of rat thoracic aorta in an endothelium-dependent manner by shikonin/alkannin and derivatives isolated from roots of Macrotomia euchroma.
Hu CM; Cheng YW; Cheng HW; Kang JJ
Planta Med; 2004 Jan; 70(1):23-8. PubMed ID: 14765288
[TBL] [Abstract][Full Text] [Related]
17. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes.
Subrahmanyam V; Renwick AB; Walters DG; Young PJ; Price RJ; Tonelli AP; Lake BG
Drug Metab Dispos; 2001 Aug; 29(8):1146-55. PubMed ID: 11454734
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.
Shao L; Hewitt M; Jerussi TP; Wu F; Malcolm S; Grover P; Fang K; Koch P; Senanayake C; Bhongle N; Ribe S; Bakale R; Currie M
Bioorg Med Chem Lett; 2008 Mar; 18(5):1674-80. PubMed ID: 18242987
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Ecstasy influence on tramadol and its main metabolite plasma concentration in rats.
Jamali B; Sheikholeslami B; Hosseinzadeh Ardakani Y; Lavasani H; Rouini MR
Drug Metab Pers Ther; 2017 Sep; 32(3):137-145. PubMed ID: 28917081
[TBL] [Abstract][Full Text] [Related]
20. Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib.
Zhao Q; Kretschmer N; Bauer R; Efferth T
Int J Cancer; 2015 Sep; 137(6):1446-56. PubMed ID: 25688715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
